Supplier · public contract awards

Lovelace Biomedical Research Institute public contracts.

Lovelace Biomedical Research Institute has won 21 public contracts between 2022 and 2026 from 4 public buyers in United States. Its most frequent buyer is National Institutes of Health - CC (12 awards). Published values total $33.4 million across 21 awards. It has also received 15 federal grants and cooperative agreements totalling $32.02 million across 15 grants; grants are not counted as contracts.

21Contracts won
4Public buyers
1Country
Sep 2026Latest award

Latest contracts won

GLP Repeat Dose Toxicology Study for A Live-Attenuated Respiratory Virus Vaccine.
Awarded by Department of Health and Human Services - National Institutes of Health · United States · $339,534
28 Sep 2026Awarded
Nicotine Flux: Investigating the Impact of Ends Output Power and Heating Element on Abuse Liability
Awarded by Department of Health and Human Services - Food and Drug Administration · United States · $3.02 million
14 Sep 2026Awarded
Rtor BIO-AMT-2312: Assessment of the Therapeutic Potential of Chloroquine and Oseltamivir in Two (2) Lethal Models of Influenza A H5N1
Awarded by Department of Health and Human Services - Office of Assistant Secretary for Preparedness and Response · United States · $3.72 million
26 Aug 2026Awarded
Sole Source Award of A 24-MONTH Period, Firm Fixed Price (FFP), Ends Toxicological Studies for Center for Tobacco Products (CTP).
Awarded by Department of Health and Human Services - Food and Drug Administration · United States · $7.06 million
19 Sep 2025Awarded
Respiratory Interaction Studies in Rodents, Ability of A Test Article to Reverse the Respiratory Depressant Effects of Opioids. TO5. Period of Perform
Awarded by Department of Health and Human Services - National Institutes of Health · United States · $211,128
21 Mar 2024Awarded
Evaluation of Potential Respiratory Stimulant. TO4. Period of Performance: March 21, 2024 - March 20, 2025.
Awarded by Department of Health and Human Services - National Institutes of Health · United States · $140,848
21 Mar 2024Awarded
Task Order 2 - Examining the Influence of Synthetic Cooling Agents on Cigarette Sensory and Subjective Effects and Use Behavior
Awarded by Department of Health and Human Services - Food and Drug Administration · United States · $1.25 million
29 Sep 2023Awarded
Radnuc 2201: Performance Verification of Institutional Radiation Dose Response for Acute Radiation Syndrome (ARS) Animal Models (rodent, Rabbit, Minip
Awarded by Department of Health and Human Services - Office of Assistant Secretary for Preparedness and Response · United States · $5.91 million
29 Sep 2023Awarded
Efficacy and Safety Evaluation of Lead Gene Therapy Candidate in Neuromuscular Junction (NMJ) Disease Mouse Models and Bioanalytical Assay Methods Dev
Awarded by Department of Health and Human Services - National Institutes of Health · United States · $1.9 million
29 Sep 2023Awarded
Task Order 1 -Title: Are Reductions in Boe, Boph, and Other Health Risk Markers Proportional to Reductions in Cigarette Smoking Upon Switching to Ends
Awarded by Department of Health and Human Services - Food and Drug Administration · United States · $3.87 million
27 Sep 2023Awarded

Contracts won by year

Contracts won by year

from the published records
20227
20238
20242
20251
20263

Published value, by currency

USD · 21 valued
$33.4 million

From published award records. Suppliers are matched by legal name; a company with a different legal name in another country (a national subsidiary, for example) has its own page. Each currency is shown on its own and never converted.

Bid with askTender

Bidding against Lovelace Biomedical Research Institute?

askTender reads every open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.

Start bidding See open tenders